Gustave Roussy Revenue and Competitors

Villejuif,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Gustave Roussy's estimated annual revenue is currently $1B per year.(i)
  • Gustave Roussy's estimated revenue per employee is $378,000

Employee Data

  • Gustave Roussy has 2766 Employees.(i)
  • Gustave Roussy grew their employee count by 5% last year.

Gustave Roussy's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head the Inpatient Unit, Drug Development DepartmentReveal Email/Phone
3
Head Bioinformatics Core FacilityReveal Email/Phone
4
Head Clinical ResearchReveal Email/Phone
5
Head Grants OfficeReveal Email/Phone
6
Head thé Genito Urinary Unit Dept Radiation OncologyReveal Email/Phone
7
Head Research DivisionReveal Email/Phone
8
Head Head Neck Surgery UnitReveal Email/Phone
9
Quality Assurance Officer - Clinical Research DepartmentReveal Email/Phone
10
Directrice du Programme Interception / Director, Cancer Interception ProgrammeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$54.4M1836%N/AN/A
#2
$18M74-4%N/AN/A
#3
$162.7M48239%N/AN/A
#4
$42.8M1448%N/AN/A
#5
$26.5M984%N/AN/A
#6
$33.2M123-2%N/AN/A
#7
$29.7M11012%N/AN/A
#8
$15.5M66-21%$29.7MN/A
#9
$1645.8M435413%N/AN/A
#10
$43.7M14718%N/AN/A
Add Company

What Is Gustave Roussy?

Gustave Roussy, premier centre de lutte contre le cancer en Europe, constitue un pôle d'expertise global contre le cancer, au service des patients. Il réunit 3 100 professionnels dont les missions sont le soin, la recherche et l'enseignement sur deux sites : à Villejuif et à Chevilly-Larue (Grand Paris). Etablissement privé d'intérêt collectif, Gustave Roussy est habilité à recevoir des dons et des legs.

keywords:N/A

N/A

Total Funding

2766

Number of Employees

$1B

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Gustave Roussy News

2022-04-20 - IO Biotech Hosting Key Opinion Leader Webinar Series

Eggermont was previously Director General of Gustave Roussy Comprehensive Cancer Center, Villejuif, France (2010-2019) and Professor of...

2022-04-20 - Frontline Immunotherapy Appears Effective in mRCC With ...

... and median overall survival (OS) was 16.0 months, Lucia Carril-Ajuria, MD, of the Institute Gustave Roussy, Villejuif, France, reported.

2022-04-20 - Martinique : Partenariat entre le CHUM et l'Institut Gustave ...

Ce jeudi 21 avril 2022, les représentants du Centre Hospitalier Universitaire de Martinique (CHUM) et de l'Institut Gustave Roussy, ont signé une convention...